Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/08/2877636/0/en/Bio-Path-Holdings-to-Announce-First-Quarter-2024-Financial-Results-on-May-15-2024.html
https://www.globenewswire.com/news-release/2024/04/19/2866293/0/en/Bio-Path-Holdings-Inc-Announces-Closing-of-1-2-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/04/18/2865747/0/en/Bio-Path-Holdings-Inc-Announces-1-2-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/04/18/2865259/0/en/Bio-Path-Holdings-Announces-Successful-Completion-of-Higher-Dose-Second-Cohort-in-Phase-1-1b-Clinical-Trial-of-BP1002-in-Refractory-Relapsed-Acute-Myeloid-Leukemia-AML-Patients.html
https://www.globenewswire.com/news-release/2024/04/15/2862615/0/en/Bio-Path-Holdings-Expands-Global-Patent-Portfolio.html
https://www.globenewswire.com/news-release/2024/04/02/2855783/0/en/Bio-Path-Holdings-Provides-2024-Clinical-and-Operational-Update.html
https://www.globenewswire.com/news-release/2024/03/08/2843016/0/en/Bio-Path-Holdings-Reports-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/01/2838733/0/en/Bio-Path-Holdings-to-Announce-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-March-8-2024.html
https://www.globenewswire.com//news-release/2024/02/21/2832603/0/en/Bio-Path-Holdings-Announces-1-for-20-Reverse-Stock-Split.html
https://www.globenewswire.com//news-release/2024/01/10/2806973/0/en/Bio-Path-Holdings-Announces-Completion-of-First-Dose-Cohort-in-Phase-1-Clinical-Trial-Evaluating-BP1002-to-Treat-Refractory-Relapsed-Lymphoma-and-Refractory-Relapsed-Chronic-Lympho.html